US Stock MarketDetailed Quotes

PROF Profound Medical

Watchlist
  • 8.290
  • -0.195-2.30%
Close May 17 16:00 ET
202.52MMarket Cap-6426P/E (TTM)

About Profound Medical Company

Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.

Company Profile

SymbolPROF
Company NameProfound Medical
Listing DateOct 29, 2019
Founded2008
CEODr. Arun Menawat,PhD
MarketNASDAQ
Employees131
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2400 Skymark Avenue,Unit 6
CityMississauga
ProvinceOntario
CountryCanada
Zip CodeL4W 5K5
Phone1-647-476-1350

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Arun Menawat,PhD
  • Chief Executive Officer and Chairman of the Board
  • 916.38K
  • Mathieu Burtnyk
  • Senior Vice-President, Product Leader TULSA-PRO; Chief Financial Officer of Profound Medical Inc.
  • 537.70K
  • Abbey Goodman
  • Chief Commercial Officer, US of Profound Medical (US) Inc
  • 645.35K
  • Hartmut Warnken
  • Chief Commercial Officer, Outside US of Profound Medical GmbH
  • 516.53K
  • Rashed Dewan
  • Chief Financial Officer of Company and Profound Medical Inc.
  • 541.98K
  • Kris Shah
  • Independent Director
  • --
  • Brian Ellacott
  • Independent Director
  • --
  • Dr. Cynthia Lavoie
  • Independent Director
  • --
  • Murielle Lortie
  • Independent Director
  • --
  • Dr. Arthur L Rosenthal
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg